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Abstract
Background: Provider-initiated HIV testing and counselling (PITC) is promoted as a means to increase HIV case
finding. We assessed the effectiveness of PITC to increase HIV testing rate and HIV case finding among outpatients
in Rwandan health facilities (HF).
Methods: PITC was introduced in six HFs in 2009-2010. HIV testing rate and case finding were compared between
phase 1 (pre-PITC) and phase 3 (PITC period) for outpatient-department (OPD) attendees only, and for OPD and
voluntary counseling & testing (VCT) departments combined.
Results: Out of 26,367 adult OPD attendees in phase 1, 4.7 % were tested and out of 29,864 attendees in phase 3,
17.0 % were tested (p < 0.001). The proportion of HIV cases diagnosed was 0.25 % (67/26,367) in phase 1 and 0.46 %
(136/29864) in phase 3 (p < 0.001). In multivariable analysis, both testing rate and case finding were significantly higher
in phase 3 for OPD attendees. In phase 1 most of the HIV testing was done in VCT departments rather than at the OPD
(78.6 % vs 21.4 % respectively); in phase 3 this was reversed (40.0 % vs 60.0 %; p < 0.001). In a combined analysis of VCT
and OPD attendees, testing rate increased from 18.7 % in phase 1 to 25.4 % in phase 3, but case finding did
not increase. In multivariable analysis, testing rate was significantly higher in phase 3 (OR 1.67; 95 % CI 1.60-1.73), but
case finding remained stable (OR 1.09; 95 % CI 0.93-1.27).
Conclusion: PITC led to a shift of HIV testing from VCT department to the OPD, a higher testing rate, but no additional
HIV case finding.
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Background
Sub-Saharan Africa has the greatest burden of HIV with
25 million people living with HIV by the end of 2012
[1]. Knowledge of HIV status is imperative for preven-
tion and timely start of HIV care [2–4]. About 30 % of
people in sub-Saharan countries have never been tested
for HIV [1]. To achieve universal HIV testing, the World
Health Organization (WHO) recommends provider initi-
ated testing and counselling (PITC) to facilitate timely
diagnosis and access to HIV related services [2]. Accord-
ing to this policy all patients presenting at health facilities
(HFs) in generalized HIV epidemics, regardless of signs or
symptoms, should be offered an HIV test on an opt-out
basis, making it a standard component of medical care [2].
PITC has mainly been implemented in antenatal (ANC)
and tuberculosis (TB) clinics in sub-Saharan countries,
with high overall testing rate levels [5–12]. Studies from
several countries (Kenya, Ethiopia, Uganda) have reported
high levels of acceptability of PITC, increased HIV testing
rate, and linkage to care after HIV diagnosis in outpatient
departments (OPDs) [13–16]. Rwanda is a country with a
generalised epidemic [1], but the adult HIV prevalence
(3 %) [17] is low compared to that of most sub-Saharan
African countries. Rwanda has a dense network of health
facilities that offer HIV testing and antiretroviral treat-
ment, and the coverage of cART (80 %) is higher than in
most countries in the region [18].
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The Rwanda Ministry of Health (MOH) adopted PITC
as a policy to increase the opportunity for HIV testing
and ensure timely HIV diagnosis among HF attendees.
We implemented PITC in 2009/2010 and assessed
whether PITC was an effective strategy to increase HIV
testing rate and HIV case finding in outpatient depart-
ments of six Rwandan HFs. In order to examine whether
PITC led to a shift from testing at voluntary counseling
and testing (VCT) clinics to testing at OPDs, we also
collected data on testing at VCT departments.
Methods
Setting
Four HFs in Musanze district (North-West Rwanda) and
four HFs in Gasabo district (Central Rwanda; area of the
capital) were purposefully selected for this study, ensur-
ing inclusion of urban and rural HFs with sufficient
numbers of attendees. All included HFs had a complete
range of HIV testing, care and treatment services.
Study design
The study consisted of three phases: in phase 1 (routine
care period; March-May 2009) PITC was not operational;
in phase 2 (preparation phase; June-November 2009)
PITC was introduced; and in phase 3 (PITC intervention
period; December 2009-February 2010) PITC was oper-
ational. PITC was introduced in six HFs while two served
as controls.
Intervention
Biomedical materials for PITC were delivered to six HFs.
Health care workers (HCWs) were trained to offer PITC,
administer HIV testing, and use registers adapted for the
study to record testing. In TB and ANC departments
PITC was already commonly practiced prior to the start
of the study, following national policy. With the excep-
tion of Ruhengeri hospital, VCT departments were oper-
ational in the other HFs, where attendees could go and
be tested on their own accord, or where they could be
referred to by health staff from other departments. Dur-
ing phase 3, PITC was newly operational in the OPD.
HCWs informed clinic attendees that it was MOH-
recommended policy to offer HIV testing to all clients
[19]. PITC was offered in three ways. Option 1 involved
a rapid test by the HCW using a finger-prick blood sample
in the consultation department. Option 2 involved a test
on a venous blood sample drawn by the HCW and sent to
the laboratory for rapid testing. Option 3 involved the
HCW offering the test, and upon consent sending the
attendee to the laboratory for a venous blood draw and
rapid testing. In all options, HCWs provided post-test
counseling. Each option was implemented at two inter-
vention sites (Table 1).
HIV testing
Both in the routine care and the intervention period, a
serial rapid test algorithm was used to test for HIV. The
first test used in the rapid test algorithm was Determine
HIV-1/2/O (Abbott Laboratories, Abbott Park, Illinois,
USA). If the Determine was negative, no further testing
was done and the patient was diagnosed as HIV nega-
tive. If positive, the UniGold (Trinity Biotech, Bray,
Ireland) test was done. In case Determine and UniGold
had discrepant results, a third test, the Capillus HIV-1/
HIV-2 (Cambridge Biotech Corp. Worcester, MA, USA),
was done. Capillus acted as a tiebreaker in order to
reach a final HIV result.
Data abstraction
Trained field workers abstracted data from registers in
the laboratory, OPD and VCT using structured forms in
phase 1 and phase 3. To enable linkage between registers
in different departments in phase 1, some adaptations
were made to the registers. During phase 2 registers
from the OPD were adapted to capture additional data
on PITC implementation. The variables introduced to
the existing registers were: HIV test offer, test accept-
ance, reason for refusal, test result received, history of
fever and number of HIV tests done in the preceding
two years. To facilitate linkage between registers from
different departments, patient reference numbers on
stickers were inserted in the registers starting from the
initial point of entry into the clinic. The following data
were abstracted: age, sex, study site, tested, and test result.
Data on test offer, test acceptance, reasons for refusal, re-
ceipt of result, history of fever and number of previous
HIV tests in preceding 2 years were abstracted only during
phase 3 in the OPD.
Outcome measures
Our study had two primary outcomes: HIV testing rate
and HIV case finding. HIV testing rate was defined as
the proportion of individuals tested for HIV out of the
total number of attendees of a department. HIV case
finding was defined as the proportion of individuals that
were diagnosed with HIV, out of the total number of at-
tendees of a department. Secondary outcome measures
were test offer, test acceptance, test result received and
reasons for refusing an HIV test during the intervention
phase. A “test offer” consisted of explicitly stating to a
patient that an HIV test would be done unless he/she
declined. “Test acceptance” indicates that the patient
consented to be tested for HIV after having been offered
a test. “Test result received” means the patient obtained
the result of the HIV test after being tested. If clinic
attendees declined to be tested for HIV, they were asked
for the reason to decline (“reasons for refusal”).
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Data management and analysis
Our analyses were limited to attendees aged 15 years or
above. The characteristics of the HF attendees were de-
scribed using percentages, medians and interquartile
ranges [IQR]. Multivariable logistic regression models
were used to establish whether PITC (i.e. phase 3) was
an independent determinant for the two main outcomes,
HIV testing rate and HIV case finding, when adjusted
for age and sex of attendees, and study site. Robust
standard errors were used to take account of clustering
effect of site. P values of <0.05 were considered statisti-
cally significant. For all analyses Stata version 11.2 was
used (Stata Corp; College Station, TX, USA).
Ethics
The Rwanda National Ethics Committee and the research
committee of the Academic Medical Center, Amsterdam,
provided approval for this study. All patients were aware
that as part of clinical care their demographic and clinical
data were registered in paper-based clinic registers. As
only such routinely collected data were abstracted from
clinic registers, and no names were entered into the
electronic study database, the ethics committees did
not require that written informed consent was sought
from patients.
Results
Characteristics of OPD attendees
During phase 1 of the study (March-May 2009), a total
of 31,204 adult attendees were registered at the OPDs of
the eight HFs included in this study. The majority (64 %)
were women, and the median age was 28 years (IQR
22–41). The number of attendees ranged from 1,878 in
Kabuye to 10,745 in Muhoza (Additional file 1: Table
S1). At the same HFs, 34,512 adult attendees were regis-
tered during phase 3 (December 2009-February 2010).
The median age of OPD attendees in phase 3 was also
28 years (IQR 22–40) and a similar proportion was
female (61 %). Again Kabuye registered the smallest
number of attendees (2,137) and Muhoza the largest
number (8,147) (Additional file 1: Table S1).
HIV testing rate at OPD
Out of 26,367 attendees in phase 1 at the six interven-
tion sites, 4.7 % (1,234) were tested for HIV. During
phase 3, out of 29,864 attendees 17.0 % (5,065) tested
for HIV (Table 2, Fig. 1a). The difference in testing rate
between the phases was 12.3 % (p < 0.001). Important
differences were observed between the sites: in Muhoza
and Kimironko testing rate increased with 20.2 % and
15.9 % respectively during phase 3, but in Kibagabaga
the testing rate decreased with 7.8 %. Rwaza had the
highest testing rate in both phase 1 and phase 3. Here,
clinic staff had introduced a form of PITC on their own
initiative prior to phase 1.
In the two control sites, testing rate increased from
5.0 % to 13.5 % (p < 0.001). One control site (Gasiza) did
not experience a change in testing rate, but the other
site (Kabuye) experienced an increase in testing rate of
17.6 % (Table 2). In this latter clinic the staff initiated a
form of PITC on their own initiative between phase 1
and 3. In multivariable analysis (adjusting for age, sex
and site), an HIV test was significantly more likely to be
done in phase 3 compared to phase 1 in both the
intervention (adjusted Odds Ratio [aOR] 4.57; 95 %
Confidence Interval [CI] 4.26–4.90; Table 3) and con-
trol sites (aOR 2.76; 95 % CI 2.34–3.24; Additional
file 1: Table S2).
Table 1 Characteristics of health facilities included in the PITC study, Rwanda 2009-10
Study site Province Level of urbanization Type Total attendeesa Interventionb Remarks
Rwaza Northern Rural Health center 7,147 Option 1 HF staff started some form of PITC already
prior to phase 1
Kinyinya Kigali City Urban Health center 7,964 Option 1
Ruhengeri Northern Semi-urban Hospital 9,191 Option 2 No VCT department at this HF; clients were
referred to Muhoza
Muhoza Northern Semi-urban Health center 26,125 Option 2 HF located next to Ruhengeri hospital (500 m).
Kibagabaga Kigali City Urban Hospital 6,771 Option 3 This hospital was affected by managerial changes
during phase 3
Kimironko Kigali City Urban Health center 13,135 Option 3
Gasiza (c) Northern Rural Health center 7,535 Control
Kabuye (c) Kigali City Semi-urban Health center 6,980 Control Staff initiated some form of PITC during phase 3
on their own initiative.
aTotal attendees: people that sought health services in all departments (Antenatal Care, Family Planning, Out-patients department, Tuberculosis department,
Voluntary counseling and testing) at the study sites during the study periods, March-May 2009 and December 2009-February 2010
bOption 1 involved a rapid test by the health care worker (HCW) using a finger-prick blood sample in the consultation department. Option 2 involved a test on a
venous blood sample drawn by the HCW and sent to the laboratory for rapid testing. Option 3 involved the HCW offering the test, and upon consent sending the
attendee to the laboratory for a venous blood draw and rapid testing. In all options, HCWs provided post-test counseling
Abbreviations: HF Health Facility, PITC Provider Initiated testing and Counseling, VCT Voluntary Counseling and testing
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Table 2 HIV testing rate and HIV case finding during phase 1 and phase 3 by study site in outpatient departments in eight health
facilities, PITC study, Rwanda 2009-2010
Phase 1 Phase 3 Differences between
phases 3 and 1



































A B C = B/A D E = D/B F = D/A G H I = H/G J K = J/H L = J/G M = I - C N = L - F
Rwaza 2,270 615 27.1 % 10 1.6 % 0.44 % 3,654 1,255 34.3 % 3 0.24 % 0.08 % 7.3 % -0.36 %
Kinyinya 2,584 34 1.3 % 6 17.6 % 0.23 % 3,488 311 8.9 % 19 6.1 % 0.54 % 7.6 % 0.31 %
Ruhengeri 3,829 195 5.1 % 8 4.1 % 0.21 % 5,259 612 11.6 % 11 1.8 % 0.21 % 6.5 % 0.00 %
Muhoza 10,745 50 0.5 % 6 12.0 % 0.06 % 8,147 1,682 20.6 % 47 2.8 % 0.58 % 20.2 % 0.52 %
Kibagabaga 2,131 313 14.7 % 30 9.6 % 1.41 % 3,465 240 6.9 % 11 4.6 % 0.32 % -7.8 % -1.09 %
Kimironko 4,808 27 0.6 % 7 25.9 % 0.15 % 5,851 965 16.5 % 45 4.7 % 0.77 % 15.9 % 0.62 %
Total 26,367 1,234 4.7 % 67 5.4 % 0.25 % 29,864 5,065 17.0 % 136 2.7 % 0.46 % 12.3 % 0.21 %
Gasiza (c) 2,959 41 1.4 % 4 9.8 % 0.14 % 2,511 22 0.9 % 4 18.2 % 0.16 % -0.5 % 0.02 %
Kabuye (c) 1,878 201 10.7 % 5 2.5 % 0.27 % 2,137 605 28.3 % 13 2.1 % 0.61 % 17.6 % 0.34 %
Total 4,837 242 5.0 % 9 3.7 % 0.19 % 4,648 627 13.5 % 17 2.7 % 0.37 % 8.5 % 0.18 %
HIV + = HIV positive individuals. (c) Control site
Fig. 1 a. HIV testing rate at OPD. b. HIV case finding at OPD
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Table 3 Multivariable logistic regression to determine the association of the PITC intervention with HIV testing rate and HIV case
finding in the outpatient department of 6 health facilities (upper panel) and in the outpatient and voluntary counseling and testing
departments combined of the same 6 health facilities (lower panel); Rwanda, 2009-2010
HIV testing rate HIV case finding
OPD only n/N (%) aOR (95 % CI) P n/N (%) aOR (95 % CI) P
Study phase
Phase 1 1,234/26,367 (4.7 %) 1 <0.001 67/26,367 (0.25 %) 1 <0.001
Phase 3 5,065/29,864 (17 %) 4.57 (4.26-4.90) 136/29,864 (0.46 %) 1.97 (1.41-2.76)
Study site
Ruhengeri 807/9,088 (8.9 %) 1 <0.001 19/9,088 (0.21 %) 1 <0.001
Muhoza 1,732/18,892 (9.2 %) 1.18 (1.08-1.30) 53/18,892 (0.28 %) 1.87 (1.06-3.31)
Kibagabaga 553/5,596 (9.9 %) 0.79 (0.69-0.89) 41/5,596 (0.73 %) 3.10 (1.69-5.68)
Kinyinya 345/6,072 (5.7 %) 0.55 (0.48-0.63) 25/6,072 (0.41 %) 2.32 (1.24-4.35)
Kimironko 992/10,659 (9.3 %) 0.97 (0.88-1.08) 52/10,659 (0.49 %) 3.13 (1.78-5.51)
Rwaza 1,870/5,924 (31.6 %) 4.65 (4.21-5.13) 13/5,924 (0.22 %) 1.19 (0.57-2.49)
Sex
Females 3,685/34,610 (10.7 %) 1 <0.001 111/34,610 (0.32 %) 1 0.078
Males 2,597/21,035 (12.4 %) 1.19 (1.13-1.26) 92/21,035 (0.44 %) 1.30 (0.98-1.73)
Age group (years)
15 - 24 2,275/19,643 (11.6 %) 1 <0.001 35/19,643 (0.18 %) 1 <0.001
25 - 34 1,732/16,687 (10.4 %) 0.93 (0.87-1.00) 65/16,687 (0.39 %) 2.09 (1.38-3.16)
35 - 44 863/7,648 (11.3 %) 0.92 (0.84-1.01) 48/7,648 (0.63 %) 3.73 (2.41-5.78)
≥45 1,270/11,470 (11.1 %) 0.77 (0.71-0.83) 42/11,470 (0.37 %) 2.38 (1.52-3.71)
OPD & VCT combined n/N (%) aOR (95 % CI) P n/N (%) aOR (95 % CI) P
Study phase
Phase 1 5,779/30,914 (18.7 %) 1 <0.001 311/30,914 (1.01 %) 1 <0.001
Phase 3 8,442/33,242 (25.4 %) 1.67 1.60-1.73 348/33,242 (1.05 %) 1.09 0.93-1.28
Study site
Ruhengeri 807/9,088 (8.9 %) 1 <0.001 19/9,088 (0.21 %) 1 <0.001
Muhoza 6,673/23,833 (28.0 %) 3.95 3.65-4.28 270/23,833 (1.13 %) 6.26 3.78-10.38
Kibagabaga 959/6,004 (16.0 %) 1.49 1.34-1.66 104/6,004 (1.73 %) 8.27 4.87-14.06
Kinyinya 1,223/6,950 (17.6 %) 1.91 1.73-2.10 94/6,950 (1.35 %) 7.22 4.25-12.28
Kimironko 1,763/11,431 (15.4 %) 1.58 1.44-1.73 153/11,431 (1.34 %) 7.39 4.41-12.38
Rwaza 2,796/6,850 (40.8 %) 7.04 6.43-7.70 19/6,850 (0.28 %) 1.57 0.81-3.06
Sex 0.417
Females 8,242/39,170 (21.0 %) 1 <0.001 413/39,170 (1.05 %) 1
Males 5,959/24,397 (24.4 %) 1.34 1.29-1.39 246/24,397 (1.01 %) 0.93 0.80-1.10
Age group (years)
15 - 24 5,498/22,867 (24.0 %) 1 <0.001 157/22,867 (0.69 %) 1 <0.001
25 - 34 4,728/19,685 (24.0 %) 1.11 1.06-1.16 270/19,685 (1.37 %) 2.02 1.65-2.46
35 - 44 1,887/8,672 (21.8 %) 0.91 0.85-0.96 128/8,672 (1.48 %) 2.42 1.91-3.06
≥45 1,933/12,133 (15.9 %) 0.54 0.51-0.58 90/12,133 (0.74 %) 1.34 1.03-1.73
Abbreviations: aOR adjusted Odds ratio, CI confidence interval, OPD outpatient department, VCT voluntary counselling and testing
Upper panel, OPD only data; information on age was missing from 783 attendees and information on sex from 586 attendees
Lower panel, OPD & VCT data combined: information on age was missing from 799 attendees and information on sex from 589 attendees
Adjusted odds ratios are adjusted for the other variables in the Table
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During phase 3, out of 29,863 eligible OPD attendees
in the intervention sites, 92.9 % (27, 753) were offered
an HIV test, 19.6 % of those accepted; of those who
accepted 93.3 % were tested, of whom 92.2 % received
results (Additional file 1: Figure S1). Among the 27,753
attendees in phase 3 who were offered an HIV test and
who declined, a reason for refusal was noted for 5,876
(21.2 %). The most common reasons reported for refus-
ing an HIV test were previous knowledge of HIV status
(33.4 %; 1,963/5,876) and lack of interest (25.3 %; 1,486/
5,876) (Additional file 1: Figure S2).
HIV case finding at OPD
The proportion of HIV positive attendees identified in
phase 1 at the intervention sites was 0.25 % (67/26,367)
while it was 0.46 % (136/29,864) during phase 3, an
absolute increase of 0.21 % (p < 0.001; Table 2, Fig. 1b).
Important differences were seen between sites. Rwaza
and Kibagabaga experienced a decrease in HIV case find-
ing. Ruhengeri did not show a change in case finding and
Muhoza and Kimironko showed an increase of 0.52 % and
0.62 % respectively. In multivariable analysis (adjusting for
age, sex and site), HIV case finding in the intervention
sites was significantly higher in phase 3 (aOR 1.97; 95 %
CI 1.41–2.76) compared to phase 1 (Table 3).
In the control sites the percentage of HIV positive
attendees increased by 0.18 % (from 0.19 % to 0.37 %; p =
0.094). There was no change in Gasiza and an increase of
0.34 % in Kabuye. The aOR for the control sites in phase 3
was 1.85 (95 % CI 0.83–4.12) (Additional file 1: Table S2)
compared to phase 1.
Characteristics of OPD and VCT attendees
In a secondary analysis we examined HIV testing rate
and case finding in the combined attendee populations
of OPD and VCT departments. The VCT departments
of the eight health facilities registered 6,541 new clients
in phase 1 and 5,129 in phase 3. During phase 1, a total
of 37,747 adult attendees were registered at the OPD
and VCT departments of the eight HFs (Additional file
1: Table S3). The majority (63 %) were women, and the
median age was 28 years (interquartile range [IQR]
22–40). The number of attendees ranged from 2,381
in Kibagabaga to 13,614 in Muhoza. At the same
HFs, 39,642 adult attendees were registered during
phase 3. The median age of attendees in phase 3 was
also 28 years (IQR 22–39) and a similar proportion
was female (60 %). Gasiza registered the smallest
number of attendees (3,154) and Muhoza the largest
number (10,219) (Additional file 1: Table S3).
HIV testing rate at OPD and VCT combined
Out of 30,914 attendees at OPDs and VCT departments
in phase 1 at the six intervention sites, 18.7 % (5,779)
were tested for HIV; during phase 3, out of 33,242
attendees, 25.4 % (8,442) were tested for HIV (p < 0.001,
Table 4, Fig. 1a). In phase 1, 78.6 % of tested attendees
(4,545/5779) were tested at the VCT; in phase 3 this had
declined to 40.0 % (3,377/8,442; p < 0.001). So there was
both a relative and an absolute decline in the number of
attendees tested at VCT departments.
In multivariable analysis (adjusting for age, sex and
site), the testing rate was significantly increased in phase
3 in both the intervention (aOR 1.67; 95 % CI 1.60–1.73;
Table 3) and control sites (aOR 1.14; 95 % CI 1.06–1.24;
Additional file 1: Table S4), compared to the rate in
phase 1.
HIV case finding at OPD and VCT combined
The proportion of HIV positive attendees identified in
phase 1 at intervention sites was 1.01 % (311/30,914)
while it was 1.05 % (348/33,242) during phase 3, an
increase of 0.04 % (p = 0.608; Table 4, Fig. 1b). In multi-
variable analysis (adjusting for age, sex and study site),
case finding was not significantly increased in phase 3 in
intervention sites (aOR 1.09; 95 % CI 0.93–1.28) com-
pared to phase 1 (Table 3).
In the control sites the percentage of HIV positive
attendees increased by 0.27 % (from 0.75 % to 1.02 %;
p = 0.094). The aOR for HIV case finding at the control
sites in phase 3 was 1.29 (95 % CI 0.89–1.86) compared to
phase 1 (Additional file 1: Table S4).
Discussion
Main findings
PITC was associated with a higher HIV testing rate
among attendees of OPDs of six Rwandan HFs, but the
increase in HIV case finding was limited. The increase in
HIV testing at the OPD was accompanied by a decrease
in HIV testing at the VCT departments. In a combined
analysis of attendees of OPD and VCT departments,
PITC was associated with an increase in HIV testing rate
but not with additional HIV case finding. The findings
from our study may be applicable to other settings with
a similar HIV epidemiologic profile, such as a relatively
low prevalence and high cART coverage, and thus may
inform decision-making in Rwanda and elswhere.
HIV testing rate
The implementation of PITC in the OPD led to a 4.5
fold increase in testing rate during the intervention
phase compared to routine care period when studying
the OPD only. A combined analysis of the OPD and
VCT showed a 1.7 fold increase in testing rate. Our data
indicate a shift of testing from VCT to OPD after the
introduction of PITC: both the absolute number of HIV
tests done at the VCT declined, and the proportion of
HIV tests done at the VCT (from 79 % to 40 %). This
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may indicate that patients who were tested in phase 3 at
OPD clinics might have been tested in the VCT depart-
ment in the absence of PITC. Alternatively, perhaps pa-
tients preferred to be tested in the OPD to avoid stigma
associated with VCT departments [20]. A study from
Zambia found that introducing PITC in nine OPDs dir-
ectly increased HIV testing rates compared with the
number tested under VCT in the same month; so PITC
provided an additional testing route rather than re-
placing VCT [15]. A study from Botswana reported an
increase of HIV testing rate following the nationwide
introduction of PITC [21]. A study from Gauteng Prov-
ince, South Africa reported a 2.9 fold increase in HIV
testing rate under PITC compared to VCT referral
model [16]. Another study from Durban, South Africa,
compared a period of standard care to a subsequent
period when all patients registered at the OPD were
given an educational intervention and offered a rapid
HIV test as a routine; both HIV testing rate and HIV
case finding increased strongly (5-fold higher weekly
HIV case finding) [22]. This report did not mention the
impact of the intervention on the total number of VCT
clients/tests, and whether a similar shifting phenomenon
occurred as in our setting.
Attendees who declined testing during the interven-
tion phase were asked by health care workers for the
reasons for refusing an HIV test. In line with Cunning-
ham et al. previous knowledge of HIV status and per-
ceived lack of interest were the most common reasons
for refusing an HIV test [23]. Previous knowledge as one
of the common reasons for declining may imply that
relatively many people were aware of their HIV status.
This finding must be seen in the context of results from
a recent global report on sub-Saharan African countries,
including Rwanda, which indicated that in Rwanda an
estimated 39 % of people were tested within the last year
and thus are likely to know their HIV status [1]. The
Rwandan demographic and health survey reported simi-
lar findings (39 % of women and 38 % of men received
results from an HIV test taken during the 12 months
prior to the survey) [17]. A South African study reported
that 31 % declined testing because they were uncomfort-
able or afraid of an HIV test and 19 % reported not feel-
ing the need to be tested [16]. Although OPD attendees
did not incur costs to get tested in our study, a Ugandan
study reported that the cost of testing and lack of per-
ceived risk were the reasons attributed to prior lack of
testing [24]. Strategies such as intensifying health educa-
tion for patients that aim to remove misconceptions
about HIV are needed [25]. The importance of retesting
despite previous negative tests should be emphasized
during post-test counseling. Another strategy may be to
establish a stigma-free and enabling environment at
health facilities by re-arranging the patient flow and fully
integrating HIV testing into other services, instead of
stand-alone HIV clinics or laboratories.
HIV case finding
Increasing HIV case finding is critical towards achieving
universal access to care and treatment services and PITC
could be an effective approach [15]. In our study, the
absolute difference in HIV case finding between phase 3
and phase 1 was 0.21 % in the OPD, which represents a
limited increase. There were important differences seen
Table 4 HIV testing rate and HIV case finding during phase 1 and 3 by study site in outpatient and voluntary counseling and testing
departments in eight health facilities, PITC study, Rwanda 2009-2010
Phase 1 Phase 3 Differences between
phases 3 and 1



































A B C = B/A D E = D/B F = D/A G H I = H/G J K = J/H L = J/G M = I - C N = L - F
Rwaza 2,863 1208 42.2 % 14 1.2 % 0.49 % 3,987 1,588 39.8 % 5 0.31 % 0.13 % -2.4 % -0.36 %
Kinyinya 3,072 522 17.0 % 30 5.7 % 0.98 % 3,878 701 18.1 % 64 9.1 % 1.65 % 1.1 % 0.67 %
Ruhengeri 3,829 195 5.1 % 8 4.1 % 0.21 % 5,259 612 11.6 % 11 1.8 % 0.21 % 6.5 % 0.00 %
Muhoza 13,614 2919 21.4 % 128 4.4 % 0.94 % 10,219 3,754 36.7 % 142 3.8 % 1.39 % 15.3 % 0.45 %
Kibagabaga 2,381 561 23.6 % 72 12.8 % 3.02 % 3,623 398 11.0 % 32 8.0 % 0.88 % -12.6 % -2.14 %
Kimironko 5,155 374 7.3 % 59 15.8 % 1.14 % 6,276 1389 22.1 % 94 6.8 % 1.50 % 14.88 % 0.35 %
Total 30,914 5,779 18.7 % 311 5.4 % 1.01 % 33,242 8,442 25.4 % 348 4.1 % 1.05 % 6.70 % 0.04 %
Gasiza (c) 3,602 684 19.0 % 16 2.3 % 0.44 % 3,154 665 21.1 % 5 0.8 % 0.16 % 2.09 % -0.29 %
Kabuye (c) 3,231 1554 48.1 % 35 2.3 % 1.08 % 3,246 1714 52.8 % 60 3.5 % 1.85 % 4.71 % 0.77 %
Total 6,833 2,238 32.8 % 51 2.3 % 0.75 % 6,400 2,379 37.2 % 65 2.7 % 1.02 % 4.42 % 0.27 %
Abbreviations: HIV+: HIV positive individuals, c control
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between sites; some had a limited increase while others
experienced a decrease in case finding. In one health
facility (Kibagabaga) this decrease was explained by the
decrease of HIV testing rate due to management
changes at this site. In another facility (Rwaza) this
decrease might be explained by the already high HIV
testing rate in phase 1. The analysis of the combined
VCT and OPD populations demonstrated that PITC was
not significantly associated with increased HIV case find-
ing. In Zambia, the integration of PITC into routine
OPD care substantially increased case finding of HIV
positive patients [15, 26]. Systematic reviews have dem-
onstrated the importance of PITC in identifying undiag-
nosed HIV infections [27, 28]. Studies have also reported
other benefits of routine HIV testing for identification of
previously undiagnosed HIV positive cases, i.e. increased
knowledge of HIV status and reduction of risk behavior
[14, 22, 29, 30]. So our data are different from findings
from other published studies regarding the effect of
PITC on HIV case finding. The differences in HIV preva-
lence and the level of HIV services delivery may explain
this discrepancy. Rwanda has a relatively low prevalence
[17], a decreasing trend of new infections and a high ART
coverage (above 80 %) compared to the countries in which
other PITC studies were done [18]. PITC led to an
increase in the HIV testing rate, but not to an increase in
case finding. This would suggest that in these settings
PITC at general OPDs is not contributing to reaching the
90-90-90 goals.
Limitations
Our study had some limitations. The study was con-
ducted in eight clinics that were purposely chosen to be
different in several respects (urban-rural, relatively high
vs. relatively low HIV prevalence, small versus very large
clinics). Rwanda is a relatively small country with rather
similar levels of health services provision across the
nation, albeit it with some variation between urban and
rural settings. Therefore we believe the results may be
applied to national scale. We implemented a before-and-
after-intervention study design; this lacks the strengths
of a randomized clinical trial and therefore the study
results should be interpreted with caution. Although we
introduced and operationalized PITC, the implementa-
tion was not fully rigorous; health workers reported that
they had offered an HIV test to 93 % of the attendees
and that 19 % of these accepted the test. The variation
between sites in characteristics and result did not allow
to draw conclusions regarding the three different testing
options. Phase 3, during which PITC was implemented
was a different season than phase 1; this may have affected
the composition of the group of attendees, and hence test-
ing history and willingness to be tested. However, seasonal
effects have a larger impact on the composition of
pediatric clinic populations than on that of adult clinic
populations. As our study population was limited to those
aged 15 years or above, we think seasonal effects have not
played a large role in the observed differences.
Conclusions
PITC led to an increase in HIV testing rate and a limited
additional HIV case finding among OPD attendees at
intervention sites compared with the routine care
period. Previous knowledge of HIV status and perceived
lack of interest were the most common reasons to de-
cline testing. Introducing PITC in the OPDs led to a
shift of HIV testing from the VCT department to the
OPD at intervention sites. HIV testing is important in
prevention, and PITC may play a large role here. How-
ever, in our setting PITC was not effective in increasing
HIV case finding. We recommend further research tak-
ing into consideration differences in HIV prevalence,
population HIV testing rates, and ART coverage.
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